Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen™

September 15, 2022

https://www.globenewswire.com/news-release/2022/09/15/2517091/0/en/Precipio-Signs-Agreement-with-Another-Major-US-Healthcare-Distributor-for-HemeScreen.html

NEW HAVEN, Conn., Sept. 15, 2022 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), has signed a distribution agreement for HemeScreen with a major distribution partner (name withheld as per partner’s policy). Following an upcoming training program and onboarding of their national coverage, this distribution channel partner’s sales team will begin promoting and driving sales of the HemeScreen platform to hundreds of their current accounts.

Read more at globenewswire.com

Related news for (PRPO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.